Related Experiment Video
Updated: May 10, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Dane particles-associated hepatitis B core antigen in patients with HBsAg-positive chronic hepatitis
Insights
Hepatitis B core antigen (HBcAg) in the blood was found in 61% of chronic hepatitis B patients. Detecting HBcAg can indicate a poor prognosis in chronic active hepatitis B.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Chronic hepatitis B virus (HBV) infection affects millions globally.
- Hepatitis B surface antigen (HBsAg) positivity indicates chronic infection.
- The role of hepatitis B core antigen (HBcAg) in disease progression requires further elucidation.
Purpose of the Study:
- To determine the prevalence of Dane particles-associated hepatitis B core antigen (HBcAg) in patients with HBsAg-positive chronic hepatitis.
- To assess the clinical and epidemiological significance of HBc antigenemia.
Main Methods:
- Radioimmunoassay was used to quantify HBcAg levels in serum samples.
- The study included 61 patients diagnosed with HBsAg-positive chronic hepatitis.
Main Results:
- HBc antigenemia was detected in 61% of the studied patients.
- Higher HBcAg levels were observed in individuals with epidemiological risk factors, particularly male homosexuals.
- HBcAg-positive patients with chronic active hepatitis exhibited a poorer prognosis compared to HBcAg-negative patients (P < 0.001).
Conclusions:
- Serum HBcAg detection is a valuable clinical and epidemiological marker in HBsAg-positive chronic hepatitis.
- The presence of HBcAg, especially in chronic active hepatitis, is associated with a less favorable disease outcome.
- HBcAg levels tend to decrease or become undetectable over time during follow-up.
Abstract:
Dane particles-associated hepatitis B core antigen (HBcAg) was determined by radioimmunoassay in 61 patients with hepatitis B surface antigen (HGsAg)-positive chronic hepatitis. HBc antigenemia was observed in 61% of patients, especially in those with epidemiological risk factors. Patients with chronic active hepatitis as well as those with chronic persistent hepatitis may have HBc antigenemia. The highest levels of HBcAg were observed in male homosexuals. Follow-up determinations indicate the general tendency of HBcAg to decrease or disappear. HBcAg-positive patients with chronic active hepatitis had a poor prognosis, whereas HBcAg-negative patients frequently had a favorable clinical course of the disease (P less than 0.001). The assay of HBcAg in the serum of patients with HBsAg-positive chronic active hepatitis is a useful parameter with both clinical and epidemiological importance.
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Antigen Presenting Cells
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
Arboviral Encephalitis
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction

